1. Field of Invention
The invention relates generally to medical devices for performing mapping and ablation procedures. More particularly, the invention relates to methods and apparatus for mapping and/or ablating cardiac walls.
2. Discussion of Related Art
The human heart is a very complex organ, which relies on both muscle contraction and electrical impulses to function properly. The electrical impulses travel through the heart walls, first through the atria and then the ventricles, causing the corresponding muscle tissue in the atria and ventricles to contract. Thus, the atria contract first, followed by the ventricles. This order is essential for proper functioning of the heart.
Over time, the electrical impulses traveling through the heart can begin to travel in improper directions, thereby causing the heart chambers to contract at improper times. Such a condition is generally termed a cardiac arrhythmia, and can take many different forms. When the chambers contract at improper times, the amount of blood pumped by the heart decreases, which can result in premature death of the person.
Techniques have been developed which are used to locate cardiac regions responsible for the cardiac arrhythmia, and also to disable the short-circuit function of these areas. According to these techniques, electrical energy is applied to a portion of the heart tissue to ablate that tissue and produce scars which interrupt the reentrant conduction pathways or terminate the focal initiation. The regions to be ablated are usually first determined by endocardial mapping techniques. Mapping typically involves percutaneously introducing a catheter having one or more electrodes into the patient, passing the catheter through a blood vessel (e.g. the femoral vein or artery) and into an endocardial site (e.g., the atrium or ventricle of the heart), and deliberately inducing an arrhythmia so that a continuous, simultaneous recording can be made with a multichannel recorder at each of several different endocardial positions.
When an arrythormogenic focus or inappropriate circuit is located, as indicated in the electrocardiogram recording, it is marked by various imaging or localization means so that cardiac arrhythmias emanating from that region can be blocked by ablating tissue. An ablation catheter with one or more electrodes can then transmit electrical energy to the tissue adjacent the electrode to create a lesion in the tissue. One or more suitably positioned lesions will typically create a region of necrotic tissue which serves to disable the propagation of the errant impulse caused by the arrythromogenic focus. Ablation is carried out by applying energy to the catheter electrodes. The ablation energy can be, for example, RF, DC, ultrasound, microwave, or laser radiation.
Atrial fibrillation together with atrial flutter are the most common sustained arrhythmias found in clinical practice. Current understanding is that atrial fibrillation is frequently initiated by a focal trigger from the orifice of or within one of the pulmonary veins. Though mapping and ablation of these triggers appears to be curative in patients with paroxysmal atrial fibrillation, there are a number of limitations to ablating focal triggers via mapping and ablating the earliest site of activation with a “point” radiofrequency lesion. One way to circumvent these limitations is to determine precisely the point of earliest activation. Once the point of earliest activation is identified, a lesion can be generated to electrically isolate the trigger with a lesion; firing from within those veins would then be eliminated or unable to reach the body of the atrium, and thus could not trigger atrial fibrillation.
Another method to treat focal arrhythmias is to create a continuous, annular lesion around the ostia (i.e., the openings) of either the veins or the arteries leading to or from the atria, thus “corralling” the signals emanating from any points distal to the annular lesion. Conventional techniques include applying multiple point sources around the ostia in an effort to create such a continuous lesion. Such a technique is relatively involved, and requires significant skill and attention from the clinician performing the procedures.
Another source of arrhythmias may be from reentrant circuits in the myocardium itself. Such circuits may not necessarily be associated with vessel ostia, but may be interrupted by means of ablating tissue either within the circuit or circumscribing the region of the circuit. It should be noted that a complete “fence” around a circuit or tissue region is not always required in order to block the propagation of the arrhythmia; in many cases simply increasing the propagation path length for a signal may be sufficient. Conventional means for establishing such lesion “fences” include a multiplicity of point-by-point lesions, dragging a single electrode across tissue while delivering energy, or creating an enormous lesion intended to inactivate a substantive volume of myocardial tissue.
U.S. Pat. No. 6,315,778 B1, entitled “Apparatus For Creating A Continuous Annular Lesion,” which is herein incorporated by reference, discloses a medical device which is capable of ablating a continuous ring of tissue around the ostia of either veins or arteries leading to or from the atria. The medical device includes a protrusion that inserts into an ostium, thereby allowing electrodes to contact tissue near the ostium.
In some instances, it is desirable to perform mapping and/or ablation procedures on a cardiac wall (or other tissue) that is not located near an ostium. In such a scenario, the lack of a protrusion may help to allow electrodes of a device contact the cardiac wall or other tissue. In other cases, mapping and/or ablation may be desired at several locations around an ostium and it would be helpful to be able to position electrodes without concern for a protrusion that may hinder contact between electrodes and the cardiac wall.
Embodiments of the present invention encompass apparatus and methods for mapping electrical activity within the heart. Embodiments of the present invention also encompass methods and apparatus for creating lesions in the heart tissue (ablating) to create a region of necrotic tissue which serves to disable the propagation of errant electrical impulses caused by an arrhythmia. The apparatus and methods described herein also may be used for mapping and ablating of tissue other than heart tissue.
One embodiment of the invention is directed to a medical device for electrophysiology procedures, comprising a catheter shaft having a proximal end and a distal end. The braided conductive member is located at the catheter shaft distal end and the braided conductive member has an undeployed configuration in which the braided conductive member has a distal end and is in a longitudinally extended configuration. The braided conductive member further includes a deployed configuration in which the braided conductive member distal end is positioned proximally relative to portions of the braided conductive member.
According to some embodiments, the braided conductive member comprises electrically conductive filaments. The braided conductive member may comprise mapping filaments and/or ablation filaments. In the deployed configuration, the braided conductive member may form a distally-facing surface with nothing protruding distally beyond the distally-facing surface.
According to some embodiments, the medical device further comprises a braided conductive member adjustment element constructed and arranged to move the braided conductive member distal end. The braided conductive member adjustment element may be a cable attached to the braided conductive member distal end, the cable being constructed and arranged to pull the braided conductive member distal end in a proximal direction. In the deployed configuration, the braided conductive member may form a distally-facing ring-shaped surface that is substantially perpendicular to a longitudinal direction of the braided conductive member. The medical device may further comprise a sheath that is advanceable over and retractable from the braided conductive member. the distal end of the catheter shaft may be steerable in some embodiments.
According to some embodiments, the medical device further comprises support elements within a proximal portion of the braided conductive member. The braided conductive member may be radially asymmetrically-shaped relative to a longitudinal axis of the braided conductive member. The braided conductive member may be longitudinally asymmetrically-shaped relative to a longitudinal axis of the braided conductive member. The medical device may further comprise a controller operatively connected to the braided conductive member. The medical device may further comprise an irrigation system.
According to a further embodiment of the invention, a catheter comprises a catheter shaft having a proximal end and a distal end, and a braided conductive member located at the catheter shaft distal end. The braided conductive member has an undeployed configuration in which a distal end of the braided conductive member is everted. The braided conductive member also has a deployed configuration in which a portion the braided conductive member is inverted.
In some embodiments, in the deployed configuration, the braided conductive member forms a distal ring of filaments. In some embodiments, in the deployed configuration, nothing protrudes distally from the distal ring. In the deployed configuration, the distal ring may be arranged such that it contactable to a substantially flat area of tissue that has no ostia.
According to another embodiment of the invention, an apparatus comprises a catheter shaft having a distal end, and a braided conductive member disposed at the distal end of the catheter shaft. The braided conductive member comprises a plurality of filaments extending from a proximal anchoring location to a distal attachment location. The braided conductive member has a maximum diameter that is a first distance from the distal attachment location, the maximum diameter being a second, larger distance from the proximal anchoring location when the braided conductive member is in a relaxed state, and the distal attachment portion is retractable to radially expand the braided conductive member and to invert the braided conductive member.
According to yet another embodiment of the invention, an apparatus comprises a catheter shaft having a distal end, and a braided conductive member disposed at the distal end of the catheter shaft. The braided conductive member comprises a plurality of filaments extending from a proximal anchoring location to a distal attachment location, the braided conductive member having a maximum diameter that is longitudinally located more than two-thirds of the distance from the proximal anchoring location to the distal attachment location when the braided conductive member is in a relaxed state.
According to another embodiment of the invention, a method of positioning a braided conductive member within a patient comprises steps of: introducing a braided conductive member into a patient in a first configuration in which a distal end of the braided conductive member is everted, and inverting the braided conductive member to place the braided conductive member in a second, deployed configuration in which the braided conductive member forms a distal annular surface with nothing protruding distally beyond the distal annular surface.
The method may further comprise retracting a sheath to expose the braided conductive member. In some embodiments, the step of inverting the braided conductive member distal end comprises actuating a braided conductive member adjustment element. Actuating the braided conductive member adjustment element may comprise pulling a cable attached to a distal end of the braided conductive member. In some embodiments, the method further comprises contacting the distal annular surface of the braided conductive member to cardiac tissue. The method may include detecting electrical impulses with the braided conductive member and transmitting the electrical impulses to a recording device. A step of activating a plurality of filaments that are part of the braided conductive member to ablate cardiac tissue may also be included as part of the method.
According to a further embodiment of the invention, a method of contacting cardiac tissue with a ring-shaped surface of a braided conductive member comprises steps of: introducing into a patient a catheter having a proximal end, a distal end, and a braided conductive member; configuring the braided conductive member such that it has a distally-facing, ring-shaped surface of filaments with nothing protruding distally from the distally-facing, ring-shaped surface; and contacting the distally-facing, ring-shaped surface to cardiac tissue.
The method may further comprise activating filaments of the braided conductive member to ablate the cardiac tissue and/or mapping electrical impulses with filaments of the braided conductive member.
The accompanying drawings are not intended to be drawn to scale. In the drawings, like components that are illustrated in various figures are represented by a like numeral. For purposes of clarity, not every component may be labeled in every drawing. In the drawings:
This invention is not limited in its application to the details of construction and the arrangement of components and acts set forth in the following description or illustrated in the drawings. The invention is capable of other embodiments and of being practiced or of being carried out in various ways. Also, the phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting. The use of “including,” “comprising,” or “having,” “containing”, “involving”, and variations thereof herein, is meant to encompass the items listed thereafter and equivalents thereof as well as additional items.
System Overview
Reference is now made to
In this description, various aspects and features of the present invention will be described. The various features of the invention are discussed separately for clarity. One skilled in the art will appreciate that the features may be selectively combined in a device depending upon the particular application. Furthermore, any of the various features may be incorporated in a catheter and associated method of use for either mapping and/or ablation procedures.
Catheter Overview
Reference is now made to
A braided conductive member adjustment element, such as a cable 22, is attached to distal end 18 of braided conductive member 28. Cable 22 may extend through a lumen (not shown) in shaft portion 12 and through the interior of braided conductive member 28. Cable 22 may be attached to distal end 18 of braided conductive member 28 using cap 24, an anchor band, or any suitable attachment or anchoring element or method known in the art. At the control handle end, cable 22 may be attached to a control element, such as a slide actuator for example, that allows a user to retract and advance cable 22. It should be noted that cable 22 is a separate element from cables 1, 3 and 6. Of course, braided conductive member adjustment element need not be a cable as any suitable element for adjusting the braided conductive member may be used. For example, a sheath may be used to push the braided conductive member over the distal tip of the braided conductive member to invert braided conductive member 28.
In operation, moving cable 22 in the proximal direction causes braided conductive member 28 to compress longitudinally and/or to expand radially, as shown in
In some embodiments, a certain amount of movement of cable 22 in the proximal direction may occur without user actuation due to the bias of the braided conductive member 28. For example, braided conductive member 28 may be longitudinally extended beyond a relaxed state by radially compressing braided conductive member 28 with a sheath 33 (see
By retracting distal end 18 of braided conductive member 28 at least a certain distance in the proximal direction, a braided conductive member annular surface 30 may be formed in a plane that is substantially perpendicular to a distal end 26 of shaft portion 12, as illustrated in
For purposes herein, a “surface” of braided conductive member 28 refers to a plurality of interlaced conductive elements, such as filaments or wires, even though the interlaced elements may not fully occupy the space considered to be the surface. In some embodiments, wires or other conductive elements may be attached to or embedded in a flexible support material such that a solid surface is present.
The annular surface formed by inverting the braided conductive member 28 may have electrodes spaced around the entire annular surface. In other embodiments, electrodes may be positioned only on a portion or portions of the ring-shaped surface.
As illustrated in
Sheath 33 may be advanced and retracted over shaft portion 12 in any suitable manner. Control handle 14 may be used to effect the advancement or retraction of sheath 33. U.S. Pat. Nos. 5,383,852, 5,462,527, and 5,611,777, which are herein incorporated by reference in their entireties, illustrate examples of control handles that can control sheath 33. As described in these patents, control handle 14 may include a slide actuator which is axially displaceable relative to the handle. The slide actuator may be connected to sheath 33 to retract sheath 33 to expose braided conductive member 28 once the distal end of the catheter has been positioned within the heart or other target location.
Braided conductive member 28 may be shaped or biased such that when sheath 33 is retracted, braided conductive member 28 expands slightly in the radial direction. In other embodiments, braided conductive member 28 may maintain its longitudinally extended shape until cable 22 or other adjustment element is pulled in the proximal direction to longitudinally compress braided conductive member 28. In still other embodiments, braided conductive member 28 may maintain a radial size similar to its relaxed state radial size when distal tip 18 is moved proximally, or even when braided conductive member 28 is inverted.
Braided conductive member 28 is, in one embodiment of the invention, a plurality of interlaced, electrically conductive filaments 34. In some embodiments, braided conductive member 28 is a wire mesh. The filaments 34 are preferably formed of metallic elements having relatively small cross sectional diameters, such that the filaments are flexible and the braided conductive member can be expanded radially outwardly. In one embodiment, the filaments may be round in cross-section, having a dimension on the order of about 0.001-0.030 inches in diameter. Alternatively, the filaments may have flat sides in cross-section, with thicknesses on the order of about 0.001-0.030 inches, and widths on the order of about 0.001-0.030 inches. The filaments may be formed of nitinol-type wire or other shaped memory alloys. Alternatively, the filaments may include non-metallic elements woven with metallic elements, with the non-metallic elements providing support to and/or separation of the metallic elements. A multiplicity of individual filaments 34 may be provided in braided conductive member 28, for example three hundred or more filaments. Instead of a multiplicity or plurality of filaments, a smaller number of filaments, or even only one continuous filament may be arranged to form braided conductive member 28. For purposes herein, the terms “filaments” or “plurality of filaments” may refer to one continuous filament that is interlaced with itself to form a braided conductive member.
Each of the filaments 34 may be electrically isolated from each other by an insulation coating. This insulation coating may be, for example, a polyamide type material. In one manner of forming an electrode, a portion of the insulation on the filaments forming an outer circumferential surface of braided conductive member 28 is removed. This arrangement allows each of the filaments 34 to form an isolated electrode, not in electrical contact with any other filament, that may be used for mapping and ablation. In some embodiments, an electrode may contact a coated section of another filament. Alternatively, specific electrodes may be permitted to contact each other to form a preselected grouping. Methods of removing insulation from filaments 34 are disclosed in PCT Publication No. WO 02/087437, which is herein incorporated by reference in its entirety. The insulation may also be removed in a preferential manner so that a particular portion of the circumferential surface of a filament 34 is exposed. In this manner, when braided conductive member 28 is radially expanded, the stripped portions of filaments may preferentially face an intended direction of mapping or ablation.
Further, in some embodiments to the invention, some of filaments 34 may be used for mapping or electrical measurement, while others of filaments 34 may be used for ablation. The mapping and ablation filaments may be activated independently or may be activated concurrently. One application of dedicating some filaments for mapping and others for ablation is using a single braided conductive member 28 to both form a lesion and measure the quality of the lesion. Such an arrangement can avoid a change of catheters during a medical procedure. Temperature sensors (not shown) also may be included on catheter shaft 12 or braided conductive member 28.
A wire (not shown) may run from each of the filaments 34 to connector portion 16 via conductors (not shown). A multiplexer or switch box may be connected to the conductors so that each filament 34 may be controlled individually. This function may be incorporated into controller 8. In some embodiments, a number of filaments 34 may be grouped together for mapping and ablation. Alternatively, each individual filament 34 may be used as a separate mapping channel for mapping individual electrical activity at a single point. Using a switch box or multiplexer to configure the signals being received by filaments 34 or ablation energy sent to filaments 34 results in a large number of possible combinations of filaments for detecting electrical activity during mapping procedures and for applying energy during an ablation procedure.
Catheter 10 may also have a reference electrode (not shown) mounted on shaft 12 so that reference the reference electrode is located outside the heart during unipolar mapping operations.
Individual control of the electrical signals received from filaments 34 allows catheter 10 to be used for bipolar (differential or between filament) type mapping as well as unipolar (one filament with respect to a reference electrode) type mapping.
Catheter 10 may be a steerable device, in some embodiments, in that the distal end 26 may be deflected by an actuator contained within control handle 14. Control handle 14 may include a rotatable thumb wheel which can be used by a user to deflect distal end 26 of the catheter. The thumb wheel (or any other suitable actuating device) is connected to one or more pull wires (not shown) which extend through shaft portion 12 and connect to distal end 18 of the catheter at an off-axis location, whereby tension applied to one or more of the pull wires causes the distal portion of the catheter to curve in a predetermined direction or directions. U.S. Pat. Nos. 5,383,852, 5,462,527, and 5,611,777 illustrate various embodiments of control handle 14 that may be used for steering catheter 10.
In some embodiments, a proximal portion of braided conductive member 28 includes support elements to aid in maintaining the shape and/or structural integrity of portions of braided conductive member 28 when distal end 18 is moved in the proximal direction. For example, support elements may include support filaments 34′ that are stronger, thicker or more rigid at their proximal ends than at their distal ends, as illustrated in
Referring to
Reference is now made to
An asymmetrically-shaped braided conductive member may allow for the formation of a ring-shaped surface that is disposed at an angle to general longitudinal direction of the braided member and/or the distal end of the catheter. The angled surface may permit better contact with certain tissue areas. In still other embodiments, inverting the braided conductive member may form a non-planar surface. For example, differing filament diameters may allow for the formation of a ring-shaped surface which includes a section that is substantially perpendicular to the catheter and a section that is disposed at an angle to the catheter. The angle of the surface relative to the catheter may change continuously across the surface in still other embodiments.
In some embodiments of the present invention, catheter 10 may be coated with a number of coatings that enhance the operating properties of braided conductive member 28. The coatings may be applied by any of a number of techniques and the coatings may include a wide range of polymers and other materials.
Braided conductive member 28 may be coated to reduce its coefficient of friction, thus reducing the possibility of thrombi adhesion to the braided conductive member as well as the possibility of vascular or atrial damage. These coatings can be combined with insulation (if present) on the filaments that make up braided conductive member 28. These coatings may be included in the insulation itself, or the coatings may be applied over the insulation layer.
Braided conductive member 28 also may be coated to increase or decrease its thermal conduction, which can improve the safety or efficacy of the braided conductive member 28. This change in thermal conduction may be achieved by incorporating thermally conductive elements or thermally insulating elements into the electrical insulation of the filaments that make up braided conductive member 28, or by adding a coating to the assembly. Polymer mixing, IBAD, or similar technology could be used to add Ag, Pt, Pd, Au, Ir, Cobalt, and others into the insulation or to coat braided conductive member 28.
In some embodiments, radioopaque coatings or markers may be used to provide a reference point for orientation of braided conductive member 28 when viewed during fluoroscopic imaging. The materials that provide radiopacity including, for example, Au, Pt, Ir, and others known to those skilled in the art. These materials may be incorporated and used as coatings as described above.
Antithrombogenic coatings, such as heparin and BH, can also be applied to braided conductive member 28 to reduce thrombogenicity to prevent blood aggregation on braided conductive member 28. These coatings can be applied by dipping or spraying, for example.
As noted above, the filament 34 of braided conductive member 28 may be constructed of metal wire materials. These materials may be, for example, MP35N, nitinol, or stainless steel. Filaments 34 may also be composites of these materials in combination with a core of another material such as silver or platinum. The combination of a highly conductive electrical core material with another material forming the shell of the wire allows the mechanical properties of the shell material to be combined with the electrical conductivity of the core material to achieve better and/or selectable performance. The choice and percentage of core material used in combination with the choice and percentage of shell material used can be selected based on the desired performance characteristics and mechanical/electrical properties desired for a particular application.
There may be times during ablation or mapping procedures when catheter 10 passes through difficult or tortuous vasculature. During these times, it may be helpful to have a guiding sheath (not shown) through which to pass catheter 10 so as to allow easier passage through the patient's vasculature.
Irrigation
It is known that for a given electrode side and tissue contact area, the size of a lesion created by radiofrequency (RF) energy is a function of the RF power level and the exposure time. At higher powers, however, the exposure time can be limited by an increase in impedance that occurs when the temperature at the electrode-tissue interface approaches a 100° C. One way of maintaining the temperature less than or equal to this limit is to irrigate the ablation electrode with saline to provide convective cooling so as to control the electrode-tissue interface temperature and thereby prevent an increase in impedance. Accordingly, irrigation of braided conductive member 28 and the tissue site at which a lesion is to be created can be provided in the present invention.
The irrigation system can also be used to deliver a contrast fluid for verifying location or changes in vessel diameter. For example, a contrast medium may be perfused prior to ablation and then after an ablation procedure to verify that there have been no changes in the blood vessel diameter. The contrast medium can also be used during mapping procedures to verify placement of braided conductive member 28. In either ablation or mapping procedures, antithrombogenic fluids, such as heparin can also be perfused to reduce thrombogenicity.
Methods of Use
Reference is now made to
In an endocardial procedure, shaft portion 12 is introduced into a patient's heart 150. Appropriate imaging guidance (direct visual assessment, camera port, fluoroscopy, echocardiographic, magnetic resonance, etc.) can be used.
In some embodiments, the braided conductive member may be configured such that it forms a distally-facing, ring-shaped surface before the braided conductive member is introduced to the heart.
Having thus described several aspects of at least one embodiment of this invention, it is to be appreciated that various alterations, modifications, and improvements will readily occur to those skilled in the art. Such alterations, modifications, and improvements are intended to be part of this disclosure, and are intended to be within the spirit and scope of the invention. Accordingly, the foregoing description and drawings are by way of example only.
This application is a national stage of PCT Application No. US2005/017337, filed May 17, 2005, which claims priority under 35 U.S.C. §119(e) to U.S. Provisional Application Ser. No. 60/571,821, entitled “METHOD AND APPARATUS FOR MAPPING AND/OR ABLATION OF CARDIAC TISSUE,” filed on May 17, 2004, which is herein incorporated by reference in its entirety.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US2005/017337 | 5/17/2005 | WO | 00 | 1/11/2008 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2005/112813 | 12/1/2005 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
3996938 | Clark, III | Dec 1976 | A |
4660571 | Hess et al. | Apr 1987 | A |
4664120 | Hess | May 1987 | A |
4699147 | Chilson et al. | Oct 1987 | A |
4709698 | Johnston et al. | Dec 1987 | A |
4921484 | Hillstead | May 1990 | A |
4940064 | Desai | Jul 1990 | A |
4998539 | Delsanti | Mar 1991 | A |
5010894 | Edhag | Apr 1991 | A |
5100423 | Fearnot | Mar 1992 | A |
5190542 | Nakao et al. | Mar 1993 | A |
5215103 | Desai | Jun 1993 | A |
5231995 | Desai | Aug 1993 | A |
5255679 | Imran | Oct 1993 | A |
5311866 | Kagan | May 1994 | A |
5313943 | Houser et al. | May 1994 | A |
5324284 | Imran | Jun 1994 | A |
5365926 | Desai | Nov 1994 | A |
5383852 | Stevens-Wright et al. | Jan 1995 | A |
5397339 | Desai | Mar 1995 | A |
5397341 | Hirschberg et al. | Mar 1995 | A |
5400783 | Pomeranz et al. | Mar 1995 | A |
5403311 | Abele et al. | Apr 1995 | A |
5409000 | Imran | Apr 1995 | A |
5415166 | Imran | May 1995 | A |
5433198 | Desai | Jul 1995 | A |
5465717 | Imran et al. | Nov 1995 | A |
5476495 | Kordis et al. | Dec 1995 | A |
5549108 | Edwards et al. | Aug 1996 | A |
5575810 | Swanson et al. | Nov 1996 | A |
5611777 | Bowden et al. | Mar 1997 | A |
5636634 | Kordis et al. | Jun 1997 | A |
5653684 | Laptewicz et al. | Aug 1997 | A |
5680860 | Imran | Oct 1997 | A |
5681280 | Bowe et al. | Oct 1997 | A |
5702438 | Avitall | Dec 1997 | A |
5722403 | McGee et al. | Mar 1998 | A |
5725552 | Kotula et al. | Mar 1998 | A |
5730128 | Pomeranz et al. | Mar 1998 | A |
5738683 | Osypka | Apr 1998 | A |
5800482 | Pomeranz et al. | Sep 1998 | A |
5813997 | Quiachon et al. | Sep 1998 | A |
5836947 | Fleischman et al. | Nov 1998 | A |
5860974 | Abele | Jan 1999 | A |
5868706 | Cox | Feb 1999 | A |
5879348 | Owens et al. | Mar 1999 | A |
5891136 | McGee et al. | Apr 1999 | A |
5893885 | Webster, Jr. | Apr 1999 | A |
5904698 | Thomas et al. | May 1999 | A |
5916213 | Haissaguerre et al. | Jun 1999 | A |
5921982 | Lesh et al. | Jul 1999 | A |
5928260 | Chin et al. | Jul 1999 | A |
5931863 | Griffin, III et al. | Aug 1999 | A |
5944738 | Amplatz et al. | Aug 1999 | A |
5951471 | de la Rama et al. | Sep 1999 | A |
5968040 | Swanson et al. | Oct 1999 | A |
5997536 | Osswald et al. | Dec 1999 | A |
6001093 | Swanson et al. | Dec 1999 | A |
6014581 | Whayne et al. | Jan 2000 | A |
6014590 | Whayne et al. | Jan 2000 | A |
6023638 | Swanson | Feb 2000 | A |
6029671 | Stevens et al. | Feb 2000 | A |
6052607 | Edwards et al. | Apr 2000 | A |
6071282 | Fleischman | Jun 2000 | A |
6119030 | Morency | Sep 2000 | A |
6142993 | Whayne et al. | Nov 2000 | A |
6146379 | Fleischman et al. | Nov 2000 | A |
6163716 | Edwards et al. | Dec 2000 | A |
6240307 | Beatty et al. | May 2001 | B1 |
6292702 | King et al. | Sep 2001 | B1 |
6315778 | Gambale et al. | Nov 2001 | B1 |
6375668 | Gifford et al. | Apr 2002 | B1 |
6468272 | Koblish et al. | Oct 2002 | B1 |
6480746 | Ingle et al. | Nov 2002 | B1 |
6500174 | Maguire et al. | Dec 2002 | B1 |
6529779 | Sutton | Mar 2003 | B1 |
6572609 | Farr et al. | Jun 2003 | B1 |
6647617 | Beatty et al. | Nov 2003 | B1 |
6673290 | Whayne et al. | Jan 2004 | B1 |
6702811 | Stewart et al. | Mar 2004 | B2 |
6786905 | Swanson et al. | Sep 2004 | B2 |
6837886 | Collins et al. | Jan 2005 | B2 |
6917834 | Koblish et al. | Jul 2005 | B2 |
20010007070 | Stewart et al. | Jul 2001 | A1 |
20010025175 | Panescu et al. | Sep 2001 | A1 |
20010047129 | Hall et al. | Nov 2001 | A1 |
20020062124 | Keane | May 2002 | A1 |
20020065459 | MacAdam et al. | May 2002 | A1 |
20020091330 | MacAdam et al. | Jul 2002 | A1 |
20020107511 | Collins et al. | Aug 2002 | A1 |
20020169473 | Sepetka et al. | Nov 2002 | A1 |
20020183638 | Swanson | Dec 2002 | A1 |
20020188289 | Hegde | Dec 2002 | A1 |
20030078574 | Hall et al. | Apr 2003 | A1 |
20030093069 | Panescu et al. | May 2003 | A1 |
20030114739 | Fuimaono et al. | Jun 2003 | A1 |
20040044277 | Fuimaono et al. | Mar 2004 | A1 |
Number | Date | Country |
---|---|---|
0 428 279 | Apr 1991 | EP |
0 771 547 | Jul 1997 | EP |
0 790 066 | Aug 1997 | EP |
0 982 047 | Mar 2000 | EP |
2271932 | Apr 1994 | GB |
54-150888 | Nov 1979 | JP |
05-505118 | Aug 1993 | JP |
11-500037 | Jan 1999 | JP |
2000-508561 | Jul 2000 | JP |
2001-509415 | Jul 2001 | JP |
2002-508989 | Mar 2002 | JP |
2003-513742 | Apr 2003 | JP |
2003-514612 | Apr 2003 | JP |
WO 9316632 | Sep 1993 | WO |
WO 9400178 | Jan 1994 | WO |
WO 9406349 | Mar 1994 | WO |
WO 9416618 | Aug 1994 | WO |
WO 9421165 | Sep 1994 | WO |
WO 9421167 | Sep 1994 | WO |
WO 9421168 | Sep 1994 | WO |
WO 9501751 | Jan 1995 | WO |
WO 9510319 | Apr 1995 | WO |
WO 9625097 | Aug 1996 | WO |
WO 9717892 | May 1997 | WO |
WO 9905971 | Feb 1999 | WO |
WO 9915225 | Apr 1999 | WO |
WO 9956812 | Nov 1999 | WO |
WO 9962413 | Dec 1999 | WO |
WO 0067656 | Nov 2000 | WO |
WO 0072909 | Dec 2000 | WO |
WO 0074555 | Dec 2000 | WO |
WO 0117451 | Mar 2001 | WO |
WO 0182814 | Nov 2001 | WO |
WO 0195820 | Dec 2001 | WO |
WO 02087437 | Nov 2002 | WO |
WO 02087456 | Nov 2002 | WO |
WO 02087679 | Nov 2002 | WO |
WO 2005008418 | Jan 2005 | WO |
WO 2005112813 | Dec 2005 | WO |
Number | Date | Country | |
---|---|---|---|
20080262337 A1 | Oct 2008 | US |
Number | Date | Country | |
---|---|---|---|
60571821 | May 2004 | US |